different glp 1 drugs The Rise of GLP-1 Medications – Magnet List of approved and pending

A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinsons disease by increasing expression of BNDF

At the same time, clinicians are getting a clearer sense of the side effects, mild and severe

However, insulin was found to be more effective at reducing fasting plasma glucose but less effective at reducing postprandial glucose levels than GLP-1RAs [42, 44]

In this article: How do GLP-1 medications work

Furthermore, the EMA has withdrawn the weight loss medication rimonabant, a selective cannabinoid type 1 receptor antagonist, due to its reported links to increased risks of depression and suicide [70]

Real-world evidence from a registry of 3865 T2DM patients showed that those treated with GLP-1 agonists had a 28% lower incidence of heart failure hospitalization compared to other glucose-lowering therapies, with the benefit being most pronounced in patients with subclinical diabetic cardiomyopathy detected by elevated NT-proBNP levels [83]